UNSPSC 51281710: Amoxicillin anhydrous

This classification denotes a penicillin antibiotic with the molecular formula C16H19N3O5S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9EM05410Q9, chemically known as amoxicillin (anhydrous), but more generally known as amoxicillin anhydrous, which bears US NIH Compound Identifier 33613. European Medicines Agency schedules amoxicillin anhydrous or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05481MIG. Most nations, for tariff purposes, schedule amoxicillin anhydrous under HS 29411010.

Amoxicillin anhydrous bears US NLM identifiers UMLS ID C2828282 and NCI Concept Code C87367. SMILES: CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3CCC(CC3)O)N)C(=O)O)C.

UNSPSC 51281710 Amoxicillin anhydrous is a Commodity code that designates a specific antibiotic active pharmaceutical ingredient, yet recent state and local solicitations tagged under this code show minimal activity directly aligned with amoxicillin procurement. The source records include a completed Illinois Department of Public Health pharmaceutical warehouse award through the MMCAP Infuse consortium for Doxycycline Hyclate and Ciprofloxacin Hydrochloride (neither amoxicillin), and a Seminole County, Florida IFB for Naloxone and drug deactivation systems, which is entirely unrelated to the code's nominal scope. When state and local procurement offices do source amoxicillin, they typically acquire it through piggyback cooperative purchasing arrangements with established pharmaceutical vendors rather than direct solicitations, and they procure it alongside broader antibiotic formularies for public health departments, county health systems, and emergency response programs.

The recent record shows no open solicitations specifically for amoxicillin anhydrous. The Illinois Department of Public Health awarded a $2,999,999.11 contract over three years to Chartwell Rx LLC on August 28, 2026 for other antibiotics via the MMCAP Infuse consortium using an IFB process, indicating that state health agencies in the region rely on cooperative purchasing vehicles and pre-negotiated contracts rather than competitive bids for individual active pharmaceutical ingredients. Geographic activity is limited to the records shown—Illinois and Florida—though the reliance on cooperative purchasing consortia such as MMCAP Infuse suggests that amoxicillin procurement, when it occurs, is likely subsumed within state-level or multi-state agreements rather than surfacing as distinct opportunities. Business development professionals should monitor cooperative purchasing catalogs and state pharmaceutical contracts more closely than open RFP or IFB activity under this specific Commodity code.